Vaxart Inc (VXRT)
0.6776
+0.02
(+2.92%)
USD |
NASDAQ |
Apr 26, 13:19
Vaxart Total Liabilities (Quarterly): 34.02M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 34.02M |
| September 30, 2023 | 34.12M |
| June 30, 2023 | 37.58M |
| March 31, 2023 | 40.10M |
| December 31, 2022 | 43.25M |
| September 30, 2022 | 53.00M |
| June 30, 2022 | 38.36M |
| March 31, 2022 | 34.01M |
| December 31, 2021 | 33.64M |
| September 30, 2021 | 36.19M |
| June 30, 2021 | 29.06M |
| March 31, 2021 | 29.63M |
| December 31, 2020 | 29.18M |
| September 30, 2020 | 23.03M |
| June 30, 2020 | 23.96M |
| March 31, 2020 | 21.27M |
| December 31, 2019 | 24.08M |
| September 30, 2019 | 23.79M |
| June 30, 2019 | 21.40M |
| March 31, 2019 | 23.73M |
| December 31, 2018 | 23.99M |
| September 30, 2018 | 24.65M |
| June 30, 2018 | 25.41M |
| March 31, 2018 | 25.43M |
| December 31, 2017 | 21.80M |
| Date | Value |
|---|---|
| September 30, 2017 | 20.80M |
| June 30, 2017 | 21.40M |
| March 31, 2017 | 22.50M |
| December 31, 2016 | 28.50M |
| September 30, 2016 | 26.50M |
| June 30, 2016 | 26.50M |
| March 31, 2016 | 9.20M |
| December 31, 2015 | 6.70M |
| September 30, 2015 | 7.50M |
| June 30, 2015 | 9.90M |
| March 31, 2015 | 7.30M |
| December 31, 2014 | 11.00M |
| September 30, 2014 | 19.40M |
| June 30, 2014 | 27.10M |
| March 31, 2014 | 24.50M |
| December 31, 2013 | 18.50M |
| September 30, 2013 | 14.10M |
| June 30, 2013 | 17.80M |
| March 31, 2013 | 14.74M |
| December 31, 2012 | 17.22M |
| September 30, 2012 | 36.54M |
| June 30, 2012 | 35.62M |
| March 31, 2012 | 35.83M |
| December 31, 2011 | 39.09M |
| September 30, 2011 | 43.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
21.27M
Minimum
Mar 2020
53.00M
Maximum
Sep 2022
32.09M
Average
33.64M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Novavax Inc | 2.514B |
| aTyr Pharma Inc | 30.18M |
| Allogene Therapeutics Inc | 130.60M |
| AIM ImmunoTech Inc | 9.147M |
| Protalix BioTherapeutics Inc | 50.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 91.83M |
| Shareholders Equity (Quarterly) | 57.80M |
| Current Ratio | 3.318 |